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Attorneys for Plaintiff

IN THE UNITED STATES DISTRICT COURT IN AND FOR
DISTRICT OF UTAH, CENTRAL DIVISION

SANMEDICA INTERNATIONAL, LLC, a
Utah limited liability company; WESTERN
HOLDINGS, LLC, a Nevada limited liability
company,
Plaintiffs,
vs.
AMAZON.COM, INC., a Delaware
corporation,

COMPLAINT
AND JURY DEMAND

Case: 2:13-cv-00169
Ass!gned To : Wells, Brooke C.
Assrgn. Date: 03/06/20 13
Description: Sanmedica International et al
v. Amazon. com

Defendant.

Plaintiffs SanMedica International, LLC (SanMedica) and Western Holdings, LLC
(Western) (together referred to as "Plaintiffs") complain against Defendant Amazon.com, Inc.
(hereafter referred to as "Defendant") as follows:
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INTRODUCTION

Plaintiff Sanmedica markets and sells a product called Serovital™. Serovital is a patentpending dietary supplement that has been shown in a double-blind, placebo-controlled study to
promote the human body's natural production of serum human growth hormone levels by a mean
over baseline of over 600%. Although there are many products that claim to assist the body in
producing growth hormone, Serovital is unique, because only it has been shown to be effective
for both men and women of a wide age range. 1
Defendant is a well-known internet retailer. Plaintiff Sanmedica offered to sell Serovital
on the Amazon website. However, Amazon refused, claiming that it did not sell dietary
supplement products that claimed to increase human growth hormone, like Serovital.
In fact, Amazon does sell products that claim to increase HGH levels and compete with
Serovital, including Original Formula GH3, Gerovital, AminoGH, Secratatropin HGH, Genf20
Plus, Controlled Labs Blue Growth, Gerovital H3 Evolution, and HGH Complex. Furthermore,
Amazon purchased advertisements with search engine providers, including Bing, Yahoo, and
Google, which produce the following results listing for searches for "Serovital" and "Serovital
hgh":
Serovital-hgh at Amazon- Qualified orders over $25 ship free.
Buy Serovital-hgh at Amazon!
www.Amazon.com

1

Plaintiff Western owns the intellectual property associated with Serovital, including the
Serovital trademark.
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Yet when the foregoing search listing for Amazon is clicked on, it takes the potential customer
seeking Serovital to the Amazon.com site to a page that offers other competing dietary
supplements for sale, but not Serovital.
Amazon's advertisements constitute false and misleading statements that are likely to
cause confusion and mistake among prospective buyers of Serovital. In fact, when typing the
words "Serovital-HGH" into Bing and Yahoo, the Amazon result is often the first or second
result on the page. And on Amazon's own drop-down search screen, when a consumer types in
the word "Serovital" numerous other search terms appear including "Serovital hgh in health and
personal care" and "Serovital hgh dietary supplement". However, when a consumer clicks on
any of these links, products marketed by competitors of plaintiff appear for purchase. Defendant
thus capitalizes on the goodwill of Plaintiffs scientifically supported product and carefullydeveloped intellectual property in order to "bait" people searching for Plaintiffs' product into
viewing Defendant's website, where Defendant is then able to "switch" the product purportedly
being offered to products other than those marketed and sold by Plaintiffs. Defendant's actions
are especially nefarious as it is using the name of Serovital, which is scientifically substantiated,
to sell products that lack scientific support for their claims. This is therefore a classic bait and
switch case-falsely claiming to have a superior product for sale in order to sell an inferior
product.
Defendant's actions violate the Lanham Act, various common law doctrines, and the
Utah Truth in Advertising Act and entitle Plaintiff to the relief set forth below.
PARTIES, JURISDICTION, AND VENUE
1.

Plaintiff Sanmedica International, LLC is a limited liability company organized
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and existing under the laws of the State of Utah. Its principal place ofbusiness is located at 5742
West Harold Gatty Drive in Salt Lake City, Utah. Sanmedica produces, markets, and sells
Serovital.
2.

Plaintiff Western Holdings, L.L.C. is a limited liability company organized and

existing under the laws of the state ofNevada. Its principal place of business is located at 1000
East William Street, suite 204 Carson City, Nevada 89701. Western owns the trademark for
Serovital and copyrights to its packaging, along with all other intellectual property associated
with Serovital. Western licenses the use of its intellectual property to Sanmedica to produce,
market, and sell Serovital.
3.

Defendant Amazon. com, Inc. is, on information and belief, a corporation

organized and existing under the laws of the state ofDelaware. Its principal place ofbusiness is
located in Seattle, Washington 98144.
4.

Subject matter jurisdiction over this action is conferred upon this Court by 28

U.S.C. § 1338 and the Lanham Act, 15 U.S.C. § 1121.
5.

This Court has supplemental jurisdiction over Plaintiffs' state-law claims pursuant

to 28 U.S.C. § 1367, in that the state law claims are integrally related to the federal claims and
arise from a common nucleus of operative facts, such that the resolution of all claims herein is in
the interests of judicial economy.
6.

The Court has personal jurisdiction over Defendant pursuant to the Utah Long

Arm Statute, Utah Code Ann.§ 78B-3-201 because Defendant has (a) transacted business in this
State and (b) engaged in tortious activity causing injury in this state. Specifically, the Defendant
has falsely advertised Plaintiffs' Serovital product for sale in the state ofUtah when it does not in
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fact offer it for sale, and transacts business generally within the state of Utah by selling and
supplying goods to the residents of the state of Utah. Furthermore, the Defendants have caused
injury to the Plaintiffs in the State of Utah.
7.

Venue is proper in this Court pursuant to 28 U.S.C. § 1391(b) and (c).
GENERAL ALLEGATIONS

The Product

8.

Plaintiff Sanmedica is engaged in the business of marketing, selling and

developing dietary and health supplements.
9.

PlaintiffSanmedica offers a 100% money-back guarantee to any consumer who is

dissatisfied with the product for any reason. In compliance with the guarantee, customers need
only return the unused portion for a full refund. Plaintiff always honors and fulfills its 100%
money-back guarantee in accordance with the terms of its guarantee.
10.

Plaintiff Sanmedica sells Serovital directly to consumers through its internet

websites and call center, and to retailers that market and sell to consumers throughout the United
States.
11.

Plaintiff Sanmedica advertises and promotes its products in numerous print,

electronic, and broadcast media in national circulation and on its own websites.
12.

Plaintiff Sanmedica markets and sells Serovital through the national retailer Ulta,

and is in the process of expanding to other national retailers.
13.

Plaintiffs Sanmedica and Western have expended a great deal of time, effort, and

money to develop, study, market, advertise, and promote Serovital.

Complaint and Jury Demand
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14.

In 2011, Sanmedica funded research at Pennington Biomedical Research Center

at Louisiana State University, one of the premier medical research institutes in the United States,
on the patent-pending formulation for Serovital.
15.

On January 14, 2012, Sanmedica received the results ofthe study.

16.

The study was a cross-over, placebo-controlled randomized study. Sixteen

healthy subjects had serum GH measured at baseline and 15, 30, 60, 90 and 120 minutes after
taking a single dose of Serovital or placebo.
17.

After 120 minutes, GH levels had increased 8-fold from baseline and were

significantly higher than placebo. In addition, a significantly higher mean area under the curve
(AU C) was observed after taking the supplement.
18.

Thus, the study showed that a single oral dose of Serovital can significantly

increase GH Levels after 120 minutes in healthy men and women.
19.

No other so-called HGH dietary supplements, including the products advertised

on Amazon, have studies like the Pennington study supporting their claims.
20.

On September 20-24, 2012, Sanmedica presented the results ofthe Pennington

study at the annual conference of the Obesity Society in San Antonio, Texas.
21.

The results of the Pennington study were so compelling that Dr. Oz, the well-

known television personality, featured the study on his national television program on October
31, 2012.
22.

Over the past year, there have been significant media coverage of HGH, such that

the consuming public has become much more informed about the positive health benefits of
HGH.
Complaint and Jury Demand
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23.

The Plaintiffs products have developed a reputation of high quality and goodwill

in the industry and the consuming public.
24.

The Serovital trademark was first used in interstate commerce on September 14,

2012. An application for registration of that trademark was filed in the United States Patent and
Trademark Office (the "USPTO") on March 5, 2012. The trademark was published for
opposition by the USPTO on December 18,2012 (a true and correct copy of a status report
regarding the trademark is attached hereto as Exhibit "A"). Plaintiffs are unaware of any
opposition to said trademark registration that has been timely filed with the USPTO or any other
claims of competing rights to said product by any other persons or entities. On February 14,
2013 the USPTO issued a notice of allowance. On March 6, 2013, Western filed a notice of use.
Western expects to the USPTO to issue a notice that the Serovital mark has registered shortly.
25.

Serovital is an arbitrary word chosen by Plaintiff Western as its trademark due to

its uniqueness.
26.

Plaintiffs have expended a great deal of time, effort, and money developing its

intellectual property rights in connection with Serovital™ including the trademark, packaging
trade dress, copyrighted label, copyrighted package insert, and copyrighted advertisements that
have appeared in numerous newspapers and magazines, as well as on Plaintiffs Web sites (e.g.,
www.Serovital.com).
Defendant's Internet Advertising

27.

Defendant has entered into financial arrangements with various internet search

engine providers, including without limitation, Bing, Yahoo, and Google, to direct searches of
keywords "Serovital" and "Serovital hgh" to a list of search results that prominently produces a
Complaint and Jury Demand
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sponsored advertisement by Defendant that states the Defendant offers to sell Serovital, with the
following language:
Serovital-hgh at Amazon- Qualified orders over $25 ship free.
Buy Serovital-hgh at Amazon!
www.Amazon.com

Copies of said search results pages from Bing and Yahoo are attached hereto respectively as
Exhibits "B" and "C".
28.

Despite the representations ofDefendant's sponsored advertisement purporting to

offer Serovital for sale to the customers seeking that specific product, when the search listing for
Amazon.com is clicked on, it takes the customer to Defendant's website to search results that
offer for sale other products, including Original Formula GH3, Gerovital, AminoGH,
Secratatropin HGH, Genf20 Plus, Controlled Labs Blue Growth, Gerovital H3 Evolution, and
HGH Complex, but not Serovital. Copies of the search results on Defendant's website for
keywords "Serovital" and "Serovital hgh" are respectively attached hereto as Exhibits "D" and
"E.''

29.

In addition, when a potential customer types the word "Serovital" or "Serovital

HGH" on the Amazon Website, a drop-down screen appears offering suggested search terms, all
of which include the Serovital trademark. The suggested search terms include "Serovital HGH
in dietary supplements" and "Serovital in Books". When a customer clicks on one of the
suggested search terms, products are offered for sale. However, none of the products are
Serovital.
30.

Plaintiffs have not granted Defendant and Defendant has no right to use the

Serovital trademark on its website or to advertise it for sale, especially since Defendant has no
Complaint and Jury Demand
Page 8 of16

Case 2:13-cv-00169-BCW Document 1 Filed 03/06/13 Page 9 of 16

intent to sell Serovital on its website. A copy of the Amazon page suggested search terms are
attached as Exhibit "F".
31.

Rather, Defendant, by falsely advertising that Serovital is available for purchase

on its website, capitalizes on the goodwill of plaintiffs product and trademark in order to '·bait"
prospective customers searching specifically for Serovital or Serovital-HGH to Defendant's
website, where Defendant can then "switch" the product falsely being advertised for sale to other
products marketed and sold by Defendant. This is a classic bait and switch case.
32.

On January 28, 2013, PlaintiffSanmedica sent a written notice to the Registered

Agent for Amazon.com, Inc., pursuant to the Utah Truth in Advertising Act (the "UTAA''), Utah
Code Ann. §13-lla-4(5), giving notice to Defendant that is was in violation ofthe provisions of
UT AA by using deceptive, misleading, and false advertising practices relating to the purported
sale of Serovital on Defendant's website. As required by the UTAA, Plaintiffs notice ( a copy
of which is attached hereto as Exhibit "G") demanded that Defendant, within 10 days of receipt
of said notice: (a) remove all advertisements on the internet that advertise, offer, state, or imply
in any way that Defendant carries or offers for sale Serovital; (b) promulgate a correction notice
with the same search engine providers containing the deceptive advertisements that states that
Serovital is not offered for sale by Defendant; and (c) send written proof of its compliance with
the demand to Plaintiff with the 10-day period.
33.

Defendant has failed to provide proof that it has complied with the demands ofthe

notice attached hereto as Exhibit "G." And Defendant continues to falsely advertise Serovital for
sale as alleged above and to infringe on Plaintiffs trademark by using that trademark in
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advertisements placed through search engine providers in a manner likely to cause confusion,
mistake or to deceive the public.
FIRST CLAIM FOR RELIEF
(Trademark Infringement under the Lanham Act)
34.

Plaintiffs re-allege and incorporate by reference paragraphs 1 through 33 above,

as though set forth fully in this count.
35.

PlaintiffWestern is the current, active, and exclusive owner ofSerovital's™ valid

and legally protected trademark, trade dress, and copyright. The trademark is active, valid and
has not been revoked or canceled. In addition, the trademarked term is an arbitrary word chosen
by Plaintiff Western as its trademark due to its uniqueness.
36.

Defendant has used and is continuing to use Plaintiff Western's trademark in

commerce without consent, and Defendant's use is likely to deceive, cause confusion, or result in
mistake as to the affiliation, connection, or association of Defendant with Plaintiffs Western and
Sanmedica and as to the availability of Serovital on Defendant's website.
37.

Defendant's unauthorized use ofPlaintiffWestern's trademark has damaged and

materially diminished the value ofPlaintiffWestern's trademark rights, and interfered with
Plaintiff Western and Sanmedica' s existing and potential business relations.
38.

Defendant's unauthorized use of the Serovital trademark has infringed upon

Plaintiff Western's trademark and trade name rights, in violation of 15 U.S.C. §§ 1114 and
1125(a).
39.

As a result of Defendant's conduct, Plaintiffs Western and Sanmedica have

suffered damages that include but are not limited to lost sales of its product, trademark
Complaint and Jury Demand
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infringement and dilution, and damage to Plaintiffs' existing and potential business relations,
together with costs ofthis action. In addition, pursuant to 15 U.S.C. § 1117(a), Plaintiffs are
entitled to an award of attorneys' fees since Defendant's acts are willful, intentional, and
egregious, making this an exceptional case.

SECOND CLAIM FOR RELIEF
(Unfair Competition Based on False Representations in violation of Lanham Act 15 U.S.C.
§ 1125(a)(l)(A))
40.

Plaintiffs re-allege paragraphs 1 through 39 of this Complaint as if set forth in full

41.

Defendant has without authorization, on or in connection with the promotion and

herein.

sale of its goods in interstate commerce, made or contributed to the making of representations of
fact that are false and misleading which are likely to cause confusion, or to cause mistake, or to
deceive purchasers and potential purchasers into believing that Plaintiffs' product, Serovital, is
available for purchase from Defendant.
42.

Defendant's acts constitute unfair competition and are misleading representations

of facts.
43.

Upon information and belief, Defendant's acts of unfair competition and

misrepresentations have led to, among other things, initial interest confusion in consumers
stemming from Defendant's "bait and switch" practices.
44.

Upon information and belief, Defendant's acts of unfair competition and

misrepresentations have deceived and, unless restrained, will continue to deceive the public,
including consumers and retailers, and have injured and unless constrained will continue to
injure Plaintiffs and the public, including consumers and retailers, causing damages to Plaintiffs
Complaint and Jury Demand
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in an amount to be determined at trial and other irreparable injury to the goodwill and reputation
of Plaintiff and its product, Serovital.
45.

Upon information and belief, Defendant's acts of unfair competition are willful,

intentional and egregious and make this an exceptional case within the meaning of 15. U.S.C.
§ 1117(a), entitling Plaintiffs to attorney's fees.
46.

Plaintiffs have no adequate remedy at law to compensate them for all the damages

the Defendant's wrongful acts have and will cause.
THIRD CLAIM FOR RELIEF
(Unjust Enrichment)

4 7.

Plaintiff realleges paragraphs 1 through 46 of this Complaint as if set forth in full

48.

Defendant has benefited from the use of Plaintiffs' name, reputation, and

herein.

goodwill without compensating the Plaintiffs.
49.

Defendant's conduct, directly or through an agent or affiliate, constitutes unjust

enrichment to the Defendant.
50.

By virtue of Defendant's unjust enrichment, Plaintiffs have suffered money

damages.
FOURTH CLAIM FOR RELIEF
(Injunctive RelieD

51.

Plaintiffs re-allege paragraphs 1 through 50 of this Complaint as if set forth in full

52.

Defendant has engaged in deceptive trade practices in violation of the Lanham

herein.

Act.
Complaint and Jury Demand
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53.

Defendant's acts will continue to deceive the public, including consumers and

retailers, unless the Court enjoins Defendant from advertising, marketing, or purporting to sell
Serovital-that it in fact has no intention to sell-or from engaging in any other false advertising
with regard to Plaintiffs' products or engaging in any other unfair competition based upon false
and misleading or confusing statements related to Serovital.
FIFTH CLAIM FOR RELIEF
(Declaratory RelieD
54.

Plaintiffs re-allege paragraphs 1 through 53 of this Complaint as if set forth in full

55.

Based on the allegations contained in this Complaint, there is a present and actual

herein.

need for a judicial declaration.
56.

Pursuant to the Declaratory Judgment Act, 28 U.S.C. § 2201, Plaintiffs are

entitled to and hereby move the Court for a judgment declaring that:
a.

Defendant's advertising is illegal, confusing, likely to confuse or

otherwise misleading.
b.

Plaintiffs have a legally protectable interest in preventing Defendant's

advertising.
c.

Plaintiffs have suffered real harm as a result of Defendant's advertising.

d.

Defendant's advertising is likely to confuse the public into believing that

the Defendant is authorized to sell Serovital and/or that the public may in fact order
Serovital through Defendant's website.
e.

Defendant should pay Plaintiffs their attorney fees and costs incurred in

prosecuting this action.
Complaint and Jury Demand
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SIXTH CLAIM FOR RELIEF
(Violation of Utah Truth in Advertising Act)

57.

Plaintiffs re-allege paragraphs 1 through 56 of this Complaint as if set forth in full

58.

Defendant's advertisements as alleged above are deceptive practices under the

herein.

Utah Truth in Advertising Act, Utah Code Ann. § 13-1 a-3 (the "UTAA"), since they cause the
likelihood of confusion or of misunderstanding by advertising the sale of Serovital on
Defendant's website, without intending to sell them to the public.
59.

The advertisements alleged above were made in and to residents of the state of

60.

Plaintiffs have suffered damages as a result of the misleading and false

Utah.

advertisements of Defendant and will continue to suffer damage unless the Court enjoins
Defendant from advertising, marketing, or purporting to sell Serovital or from engaging in any
other false advertising with regard to Plaintiffs' product or engaging in any other unfair
competition based upon false and misleading or confusing statements related to Serovital.
61.

In addition to injunctive relief under the UT AA, Plaintiffs are entitled to recover

actual damages it sustains as a consequence of Defendant's violation of the UTAA, together with
costs and attorney's fees incurred in bringing this claim.
62.

Pursuant to the UT AA, Plaintiffs are entitled to statutory damages of $2,000.00

per violation, or in other words, Plaintiffs are entitled to $2,000.00 for each potential customer
who clicked on an offending link.

PRAYER FOR RELIEF
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WHEREFORE, Plaintiffs respectfully request the following relief:
A.

A permanent injunction against Defendant, its officers, agents, servants,

employees, and attorneys, and upon those persons in active concert or participation with them
who receive actual notice of the injunction by personal service or otherwise, enjoining and
restraining them from directly or indirectly:
1.

Advertising, marketing, or offering to sell Serovital in any source,

including any internet search engine provider, or in any manner on Defendant's website;
or
2.

Publishing, displaying, distributing, disseminating or using, or permitting

or entering into or performing any agreement for the publication, display, distribution, or
use of Plaintiffs' trademarked name, Serovital.
B.

An order requiring Defendant to immediately remove, or cause to be removed, all

advertisements that purport to or imply that Defendant sells Serovital on its website.
C.

Judgment on all claims for the damages suffered by Plaintiffs as a result of

Defendant's unfair competition and deceptive acts and practices, in an amount to be determined
at trial.
D.

Judgment on the First, Second, and Sixth Claims for Relief awarding Plaintiff

reasonable attorney's fees in this action, pursuant to 15 U.S.C. § 1117 and Utah Code Ann. §13lla-4, respectively.
E.

Judgment awarding statutory damages under the Plaintiffs' UTAA claim.

F.

Judgment awarding Defendant's profits to Plaintiffs, and awarding damages

sustained by the Plaintiffs and the costs of the action.
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G.

Judgment for punitive damages as a result of Defendant's outrageous conduct and

willful and intentional violations.
H.

Judgment on all claims awarding Plaintiffs costs and attorney's fees in this action.

I.

Declaratory relief as requested.

J.

Injunctive Relief as requested.

K.

Such other relief as the Court may deem just and equitable.
DEMAND FOR JURY TRIAL

Plaintiffs demand a trial by jury of all matters that may be tried by a jury.
DATED this

~r

day ofMarch, 2013.
PRICE PARKINSON & KERR, PLLC

By:

Mark J. Williams
Jason M. Kerr
Attorneys for Plaintiffs
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